SDL logo

Span Divergent Ltd

SDL·NSE·
27.89 -0.26 (-0.92%)
Market Cap21.40 Cr
PE Ratio
Volume11
Day High - Low30.75 - 27.89
52W High-Low51.49 - 21.20

Span Divergent Ltd (SDL): company summary

Span Divergent Ltd (SDL) is a micro-cap Healthcare company valued at ₹21 crore operating in Pharmaceuticals on the NSE and BSE.

Span Divergent Ltd (SDL) is a micro-cap Healthcare company valued at ₹21 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move
Span Divergent Ltd last traded at ₹27.89, modestly down 0.92% on the day.
Financial performance
Revenue has been growing steadily at 10.5% a year over three years. Return on equity is -41.5%.
Valuation multiples
A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at 1.44 times book value.
Things to watch
The price sits 46% below its 52-week high.

Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
2.2/10
Poor
Fair Value
Sign in to see
ROE
-41.50%
Weak
P/E
Debt / Equity
0.48
Moderate
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

Day27.89
30.75
52W21.20
51.49
DocStoX take

Supported by growth (7.5) and valuation (6.0), but held back by quality (0.0). Growth looks strong at 7.5, but that is offset by quality at 0.0 and momentum at 1.0. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
2.2
/10
Poor
Quality
Weak
ROE -41.5%
Valuation
Fair
P/B 1.4× on assets (no earnings to value)
Growth
Strong
Revenue +18.0% 5Y CAGR
Risk
Elevated
D/E 0.48
Momentum
Weak
22% of 52-week range

At a glance

Market Cap
₹21 Cr
52W High / Low
₹51 / ₹21
Dividend Yield
0.00%
Promoter Holding
48.13%
EPS (TTM)
₹-1.68
Book Value
₹20.46

Key highlights

  • Revenue compounding 18% a year
  • Loss-making in some of the last 5 years
  • Quality is weak (0.0/10)
1 Positive4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Span Divergent Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.